相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients
Stephen Y. Wang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
Giuseppe Boriani et al.
EUROPEAN HEART JOURNAL (2019)
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
Somasekhara R. Balla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Roopinder K. Sandhu et al.
EUROPEAN HEART JOURNAL (2016)
分享论文
